RICTOR and hepatocellular carcinoma: In the same vein, in a recent study, Zhang and coworkers revealed miR-497 as an important TS-miR demonstrating the capability of this molecule to contrast proliferation, invasion, and metastasis by targeting the Rictor/AKT pathway in hepatoma cells [22].